e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Phenotyping asthma with biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
IL-17A in severe asthma, severe asthma with fungal sensitisation and ABPA
Livingstone Chishimba (Manchester, United Kingdom), Livingstone Chishimba, Robert Niven, Marcin Fraczec, Angela Simpson, Paul Bowyer, David Denning
Source:
International Congress 2015 – Phenotyping asthma with biomarkers
Session:
Phenotyping asthma with biomarkers
Session type:
Oral Presentation
Number:
1464
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Livingstone Chishimba (Manchester, United Kingdom), Livingstone Chishimba, Robert Niven, Marcin Fraczec, Angela Simpson, Paul Bowyer, David Denning. IL-17A in severe asthma, severe asthma with fungal sensitisation and ABPA. Eur Respir J 2015; 46: Suppl. 59, 1464
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Are there differences in the bronchoalveolar lavage (BAL) cytokine profile in children with and without allergic asthma?
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Lung microbiome is associated with asthma severity in fungal associated asthma
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
IgE expression in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2013 –Asthma
Year: 2013
Sputum eosinophilia in severe allergic asthma is not a reliable marker of omalizumab treatment
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Refractory severe asthma: Is presence of aspergillus in broncho-alveolar lavage significant?
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
Higher doses of inhaled steroid are associated with bacterial bronchitis in children with severe therapy resistant asthma (STRA)
Source: International Congress 2016 – Paediatric asthma: from amniotic fluid to dirty streets
Year: 2016
Elevated Tryptase concentration In bronchoalveolar lavage fluid from patients with chronic eosinophilic pneumonia
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Bronchial hyperactivity in perimenstrual asthma is higher than in non-PMA asthmatics and correlates with sputum levels of eotaxin and IL-4
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Pulmonary and systemic inflammation in patients with AECOPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Periostin in lower airway samples and serum, a novel asthma marker?
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Asthma
Source: Respipedia Article
Year: 2018
Vitamin D deficiency in asthma patients with allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Bronchial hyperresponsivenes, atopy and BAL eosinophils in persistent middle lobe syndrome (MLS)
Source: Annual Congress 2006 - Advances in diagnosis and treatment of pulmonary diseases in children
Year: 2006
The allergy profile and accompanying sinonasal pathologies in patients with bronchial asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Targeting PI3KΔ or JAK in T-cells from COPD and severe asthma subjects reduces corticosteroid insensitive inflammatory responses
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Mechanisms of noneosinophilic asthma
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept